Intelligent Bio Solutions Inc. (INBS), a medical technology company, on Wednesday announced a significant partnership with Quantum Traffic Management or Quantum TM, a UK-based traffic management provider, to implement its Intelligent Fingerprinting Drug Testing Solution across 10 nationwide sites.
Quantum TM, with over 30 years of industry experience, previously relied on external testing providers but faced delays and inefficiencies.
INBS' technology enables quicker, on-the-spot drug screening, offering a more efficient and hygienic alternative.
This adoption expands INBS' portfolio, which now includes over 400 accounts worldwide.
The company plans to enter the US market in 2025, following its FDA 510(k) submission in December 2024.
The company's fingerprint-based drug screening system is gaining traction in sectors like construction, manufacturing, and transport.
Currently, INBS is trading at $1.42 down by 1.39%.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.